$8.02
-0.15-1.84%
最終更新: Oct 16, 4:26 PM
$8.02
-0.15-1.84%
Benzinga
Benzinga
Benzinga
月曜日, 10 19
Benzinga
© 2026 Benzinga | All Rights Reserved
Sagimet Biosciences (SGMT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.27 | $-0.36 | $-0.41 | $-0.40 |
| Actual | $-0.26 | $-0.33 | $-0.29 | $-0.40 |
| Surprise | +3.70% | +8.33% | +29.3% | 0.00% |
| Revenue | ||||
| Estimate | — | — | $1.3M | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | -100.0% | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.26 | $-0.28 |
| Revenue | ||
| Consensus | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.26 | $-0.27 | 3.70 % |
| Q1 | May 12, 2026 | $-0.33 | $-0.36 | 8.33 % |
| Q4 | Mar 11, 2026 | $-0.29 | $-0.41 | 29.3 % |
| Q3 | Nov 13, 2025 | $-0.40 | $-0.40 | 0.00 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q4 | Mar 11, 2026 | $0 | $1.25M | -100.0 % |